Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005995
Filing Date
2025-08-18
Accepted
2025-08-18 16:36:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4769
  Complete submission text file 0001950047-25-005995.txt   6230
Mailing Address C/O PENINSULA PHARMACEUTICALS, INC. 1751 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address
Podlesak Dennis (Reporting) CIK: 0001314595 (see all company filings)

Type: 144

Mailing Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 781-419-1400
Syndax Pharmaceuticals Inc (Subject) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37708 | Film No.: 251228393
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)